Nitric oxide synthases: Targets for therapeutic strategies in neurological diseases

Cellular and Molecular Life Sciences

Volumn 55, Issue 8-9, 1999, Pages 1029-1035

  Chabrier, P E ^a   Demerle Pallardy C ^a   Auguet, M ^a  

^a IPSEN   (France)

Author keywords

Free radicals; Neurological diseases; Neuroprotection; Nitric oxide; Nitric oxide synthase inhibition; Oxidative damage

Indexed keywords

AMINOGUANIDINE; ANTIOXIDANT; ARL 17477; EXCITOTOXIN; GLUTAMIC ACID; N [4 [4 [(3,4 DIHYDRO 6 HYDROXY 2,5,7,8 TETRAMETHYL 2H 1 BENZOPYRAN 2 YL)CARBONYL] 1 PIPERAZINYL]PHENYL] 2 THIOPHENECARBOXIMIDAMIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PEROXYNITRITE; SUPEROXIDE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG STRUCTURE; HUNTINGTON CHOREA; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; REVIEW;

EID: 0032797262     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050353     Document Type: Review

References (73)

1. 1 Vincent S. R. and Kimura H. (1992) Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 46: 755-784
2. 2 Garthwaite J., Charles S. L. and Chess-Williams R. (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336: 385-388
3. 3 Demerle-Pallardy C., Lonchampt M. O., Chabrier P. E. and Braquet P. (1993) Nitric oxide synthase induction in glial cells: effect on neuronal survival. Life Sci. 52: 1883-1890
4. 4 Beckman J. S., Beckman T. W., Chen J., Marshall P. A. and Freeman B. A. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87: 1620-1624
5. 5 Trotti D., Rossi D., Gjesdal O., Levy L. M., Racagni G., Danbolt N. C. et al. (1996) Peroxynitrite inhibits glutamate transporter subtypes. J. Biol. Chem. 271: 5976-5979
6. 6 Malinski T., Bailey F., Zhang Z. G. and Chopp M. (1993) Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 13: 355-358
7. 7 Tominaga T., Sato S., Ohnishi T. and Ohnishi S. T. (1993) Potentiation of nitric oxide formation following bilateral carotid occlusion and focal cerebral ischemia in the rat: in vivo detection of the nitric oxide radical by electron paramagnetic resonance spin trapping. Brain Res. 614: 342-346
8. 8 Kader A., Frazzini V. I., Solomon R. A. and Trifiletti R. R. (1993) Nitric oxide production during focal cerebral ischemia in rats. Stroke 24: 1709-1716
9. 9 Endoh M., Maiese K. and Wagner J. A. (1994) Expression of the neural form of nitric oxide synthase by CA1 hippocampal neurons and other central nervous system neurons. Neuroscience 63: 679-689
10. 10 Zhang Z. G., Chopp M., Gautam S., Zaloga C., Zhang R. L., Schmidt H. H. et al. (1994) Upregulation of neuronal nitric oxide synthase and mRNA, and selective sparing of nitric oxide synthase-containing neurons after focal cerebral ischemia in rat. Brain Res. 654: 85-95
11. 11 Earley B., Canney M., Clune B., Caldwell M., Leonard B. E. and Junien J. L. (1996) The effects of MK-801, ifenprodil, JO 1784, JO 1994 and JO 1997 on PK 11195 receptor binding, nitric oxide synthase (NO synthase) activity and infarct volume in a mouse model of focal cerebral ischaemia. Neurochem. Int. 28: 509-521
12. 12 Zhang F., Xu S. and Iadecola C. (1995) Time dependence of effect of nitric oxide synthase inhibition on cerebral ischemic damage. J. Cereb. Blood Flow Metab. 15: 595-601
13. 13 Ischiropoulos H., Zhu L., Chen J., Tsai M., Martin J. C., Smith C. D. et al. (1992) Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys. 298: 431-437
14. 14 Forman L. J., Liu P., Nagele R. G., Yin K. and Wong P. Y. (1998) Augmentation of nitric oxide, superoxide, and peroxynitrite production during cerebral ischemia and reperfusion in the rat. Neurochem. Res. 23: 141-148
15. 15 Fukuyama N., Takizawa S., Ishida H., Hoshiai K., Shinohara Y. and Nakazawa H. (1998) Peroxynitrite formation in focal cerebral ischemia-reperfusion in rats occurs predominantly in the peri-infarct region. J. Cereb. Blood Flow Metab. 18: 123-129
16. 16 Ashwal S., Tone B., Tian H. R., Cole D. J. and Pearce W. J. (1998) Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion. Stroke 29: 1037-1046
17. 17 Wada K., Chatzipanteli K., Busto R. and Dietrich W. D. (1998) Role of nitric oxide in traumatic brain injury in the rat. J. Neurosurg. 89: 807-818
18. 18 Mesenge C., Charriaut-Marlangue C., Verrecchia C., Allix M., Boulu R. R. and Plotkine M. (1998) Reduction of tyrosine nitration after N omega-nitro-L-arginine-methylester treatment of mice with traumatic brain injury. Eur. J. Pharmacol. 353: 53-57
19. 19 Nowicki J. P., Duval D., Poignet H. and Scatton B. (1991) Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur. J. Pharmacol. 204: 339-340
20. 20 Carreau A., Duval D., Poignet H., Scatton B., Vige X. and Nowicki J. P. (1994) Neuroprotective efficacy of N omega-nitro-L-arginine after focal cerebral ischemia in the mouse and inhibition of cortical nitric oxide synthase. Eur. J. Pharmacol. 256: 241-249
21. 21 Margaill I., Allix M., Boulu R. G. and Plotkine M. (1997) Dose-and time-dependence of L-NAME neuroprotection in transient focal cerebral ischaemia in rats. Br. J. Pharmacol. 120: 160-163
22. 22 Nagafuji T., Sugiyama M., Matsui T. and Koide T. (1993) A narrow therapeutical window of a nitric oxide synthase inhibitor against transient ischemic brain injury. Eur. J. Pharmacol. 248: 325-328
23. 23 Spinnewyn B., Cornet S., Auguet M. and Chabrier P. E. (1999) Synergistic protective effects of antioxidant and nitric oxide synthase inhibitor in transient focal ischemia. J. Cereb. Blood Flow Metab. 19: 139-143
24. 24 Mesenge C., Verrecchia C., Allix M., Boulu R. R. and Plotkine M. (1996) Reduction of the neurological deficit in mice with traumatic brain injury by nitric oxide synthase inhibitors. J. Neurotrauma 13: 11-16
25. 25 Lu Y. C., Liu S., Gong Q. Z., Hamm R. J. and Lyeth B. G. (1997) Inhibition of nitric oxide synthase potentiates hypertension and increases mortality in traumatically brain-injured rats. Mol. Chem. Neuropathol. 30: 125-137
26. 26 Guilmard C., Auguet M. and Chabrier P. L. (1998) Comparison between endothelial and neuronal nitric oxide pathways in rat aorta and gastric fundus. Nitric Oxide Biol. Chem. 2: 147-154
27. 27 O'Neill M. J., Hicks C. and Ward M. (1996) Neuroprotective effects of 7-nitroindazole in the gerbil model of global cerebral ischaemia. Eur. J. Pharmacol. 310: 115-122
28. 28 Nanri K., Montecot C., Springhetti V., Seylaz J. and Pinard E. (1998) The selective inhibitor of neuronal nitric oxide synthase, 7-nitroindazole, reduces the delayed neuronal damage due to forebrain ischemia in rats. Stroke 29: 1248-1253
29. 29 Yoshida T., Limmroth V., Irikura K. and Moskowitz M. A. (1994) The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. J. Cereb. Blood Flow Metab. 14: 924-929
30. 30 Zhang Z. G., Reif D., Macdonald J., Tang W. X., Kamp D. K., Gentile R. J. et al. (1996) ARL 17477, a potent and selective neuronal NOS inhibitor decreases infarct volume after transient middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 16: 599-604
31. 31 Escott K. J., Beech J. S., Haga K. K., Williams S. C., Meldrum B. S. and Bath P. M. (1998) Cerebroprotective effect of the nitric oxide synthase inhibitors, 1-(2-trifluoromethylphenyl) imidazole and 7-nitro indazole, after transient focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 18: 281-287
32. 32 Chabrier P. E., Spinnewyn B., Cornet S., Roussillot C., Pignol B., Buisson A. et al. (1998) New potent neuroprotective agents are inhibitors of neuronal NO synthases and scavengers of oxygen free radicals: in vivo studies. II. Effect on rat brain focal ischemia, 28th Annu. Meet. Soc. Neurosci., Los Angeles, 7-12 November (Abstr. 483.9)
33. 33 Auguet M., Viossat I., Marin J. G. and Chabrier P. E. (1995) Selective inhibition of inducible nitric oxide synthase by agmatine. Jpn. J. Pharmacol. 69: 285-287
34. 34 Iadecola C., Zhang F. and Xu X. (1995) Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am. J. Physiol. 268: R286-R292
35. 35 Gilad G. M., Salame K., Rabey J. M. and Gilad V. H. (1996) Agmatine treatment is neuroprotective in rodent brain injury models. Life Sci. 58: L-6
36. 36 Spinnewyn B., Surget M. O., Pallardy C. and Chabrier P. E. (1998) Comparison of the effects of aminoguanidine and 7-nitroindazole in a rat model of focal cerebral ischemia. J. Cereb. Blood Flow Metab. 17 (Suppl. 1): S104
37. 37 Nagayama M., Zhang F. and Iadecola C. (1998) Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats. J. Cereb. Blood Flow Metab. 18: 1107-1113
38. 38 Huang Z., Huang P. L., Panahian N., Dalkara T., Fishman M. C. and Moskowitz M. A. (1994) Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265: 1883-1885
39. 39 Iadecola C., Zhang F., Casey R., Nagayama M. and Ross M. E. (1997) Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 17: 9157-9164
40. 40 Huang Z., Huang P. L., Ma J., Meng W., Ayata C., Fishman M. C. et al. (1996) Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J. Cereb. Blood Flow Metab. 16: 981-987
41. 41 Good P. F., Hsu A., Werner P., Perl D. P. and Olanow C. W. (1998) Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 57: 338-342
42. 42 Beal M. F., Ferrante R. J., Browne S. E., Matthews R. T., Kowall N. W. and Brown R. H. J. (1997) Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 42: 644-654
43. 43 Good P. F., Werner P., Hsu A., Olanow C. W. and Perl D. P. (1996) Evidence of neuronal oxidative damage in Alzheimer's disease. Am. J. Palhol. 149: 21-28
44. 44 Shergill J. K., Cammack R., Cooper C. E., Cooper J. M., Mann V. M. and Schapira A. H. (1996) Detection of nitrosyl complexes in human substantia nigra, in relation to Parkinson's disease. Biochem. Biophys. Res. Commun. 228: 298-305
45. 45 Schapira A. H., Cooper J. M., Dexter D., Clark J. B., Jenner P. and Marsden C. D. (1990) Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54: 823-827
46. 46 Ferrante R. J., Kowall N. W., Beal M. F., Richardson E. P. J., Bird E. D. and Martin J. B. (1985) Selective sparing of a class of striatal neurons in Huntington's disease. Science 230: 561-563
47. 47 Norris P. J., Waldvogel H. J., Faull R. L., Love D. R. and Emson P. C. (1996) Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease. Neuroscience 72: 1037-1047
48. 48 Li X. J., Sharp A. H., Li S. H., Dawson T. M., Snyder S. H. and Ross C. A. (1996) Huntingtin-associated protein (HAP1): discrete neuronal localizations in the brain resemble those of neuronal nitric oxide synthase. Proc. Natl. Acad. Sci. USA 93: 4839-4844
49. 49 Hyman B. T., Marzloff K., Wenniger J. J., Dawson T. M., Bredt D. S. and Snyder S. H. (1992) Relative sparing of nitric oxide synthase-containing neurons in the hippocampal formation in Alzheimer's disease. Ann. Neurol. 32: 818-820
50. 50 Kowall N. W. and Beal M. F. (1988) Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease. Ann. Neurol. 23: 105-114
51. 51 Norris P. J., Faull R. L. and Emson P. C. (1996) Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex, visual cortex and hippocampus of control and Alzheimer's disease brains. Brain Res. Mol. Brain Res. 41: 36-49
52. 52 Vodovotz Y., Lucia M. S., Flanders K. C., Chesler L., Xie Q. W., Smith T. W. et al. (1996) Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J. Exp. Med. 184: 1425-1433
53. 53 Wallace M. N., Geddes J. G., Farquhar D. A. and Masson M. R. (1997) Nitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques. Exp. Neurol. 144: 266-272
54. 54 Beckman J. S., Carson M., Smith C. D. and Koppenol W. H. (1993) ALS, SOD and peroxynitrite. Nature 364: 584
55. 55 Wiedau-Pazos M., Goto J. J., Rabizadeh S., Gralla E. B., Roe J. A., Lee M. K. et al. (1996) Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271: 515-518
56. m for hydrogen peroxide. Proc. Natl. Acad. Sci. USA 93: 5709-5714
57. 57 Chou S. M., Wang H. S. and Komai K. (1996) Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: an immunohistochemical study. J. Chem. Neuroanat. 10: 249-258
58. 58 Schulz J. B., Matthews R. T., Muqit M. M., Browne S. E. and Beal M. F. (1995) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64: 936-939
59. 59 Ara J., Przedborski S., Naini A. B., Jackson-Lewis V., Trifiletti R. R., Horwitz J. et al. (1998) Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc. Natl. Acad. Sci. USA 95: 7659-7663
60. 60 Hantraye P., Brouillet E., Ferrante R., Palfi S., Dolan R., Matthews R. T. et al. (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat. Med. 2: 1017-1021
61. 61 Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V. L. and Dawson T. M. (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. USA 93: 4565-4571
62. 62 Castagnoli K., Palmer S., Anderson A., Bueters T. and Castagnoli N. J. (1997) The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Chem. Res. Toxicol. 10: 364-368
63. 63 Matthews R. T., Yang L. and Beal M. F. (1997) S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity. Exp. Neurol. 143: 282-286
64. 64 Schulz J. B., Matthews R. T., Jenkins B. G., Brar P. and Beal M. F. (1995) Improved therapeutic window for treatment of histotoxic hypoxia with a free radical spin trap. J. Cereb. Blood Flow Metab. 15: 948-952
65. 65 Connop B. P., Boegman R. J., Beninger R. J. and Jhamandas K. (1997) Malonate-induced degeneration of basal forebrain cholinergic neurons: attenuation by lamotrigine, MK-801, and 7-nitroindazole. J. Neurochem. 68: 1191-1199
66. 66 Connop B. P., Boegman R. J., Beninger R. J. and Jhamandas K. (1996) Attenuation of malonate-induced degeneration of the nigrostriatal pathway by inhibitors of nitric oxide synthase. Neuropharmacology 35: 459-465
67. 67 Maragos W. F. and Silverstein F. S. (1995) Inhibition of nitric oxide synthase activity attenuates striatal malonate lesions in rats. J. Neurochem. 64: 2362-2365
68. 68 Schulz J. B., Huang P. L., Matthews R. T., Passov D., Fishman M. C. and Beal M. F. (1996) Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice. J. Neurochem. 67: 430-433
69. 69 Meda L., Cassatella M. A., Szendrei G. I., Otvos L. J., Baron P., Villalba M. et al. (1995) Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374: 647-650
70. 70 Rossi F. and Bianchini E. (1996) Synergistic induction of nitric oxide by beta-amyloid and cytokines in astrocytes. Biochem. Biophys. Res. Commun. 225: 474-478
71. 71 Lockhart B. P., Benicourt C., Junien J. L. and Privat A. (1994) Inhibitors of free radical formation fail to attenuate direct beta-amyloid25-35 peptide-mediated neurotoxicity in rat hippocampal cultures. J. Neurosci. Res. 39: 494-505
72. 72 Ferrante R. J., Shinobu L. A., Schulz J. B., Matthews R. T., Thomas C. E., Kowall N. W. et al. (1997) Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/ zinc superoxide dismutase mutation. Ann. Neurol. 42: 326-334
73. 73 Cha C. I., Kim J. M., Shin D. H., Kim Y. S., Kim J., Gurney M. E. et al. (1998) Reactive astrocytes express nitric oxide synthase in the spinal cord of transgenic mice expressing a human Cu/Zn SOD mutation. Neuroreport 9: 1503-1506